OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Release Date
2023
(9)
2022
(6)
2024
(4)
2025
(2)
2021
(2)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Discovery of new 1
H
-pyrazolo[3,4-
d
]pyrimidine derivatives as anticancer agents targeting EGFR
WT
and EGFR
T790M
.
Not available
S-EPMC9466626
|
biostudies-literature
Cite
New Anticancer Theobromine Derivative Targeting EGFR
WT
and EGFR
T790M
: Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies.
Not available
S-EPMC9500845
|
biostudies-literature
Cite
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study.
Not available
S-EPMC9867533
|
biostudies-literature
Cite
Anticancer derivative of the natural alkaloid, theobromine, inhibiting EGFR protein: Computer-aided drug discovery approach.
Not available
S-EPMC9997933
|
biostudies-literature
Cite
New Theobromine Apoptotic Analogue with Anticancer Potential Targeting the EGFR Protein: Computational and
In Vitro
Studies.
Not available
S-EPMC11007702
|
biostudies-literature
Cite
Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects.
Not available
S-EPMC9317904
|
biostudies-literature
Cite
A Theobromine Derivative with Anticancer Properties Targeting VEGFR-2: Semisynthesis, in silico and in vitro Studies.
Not available
S-EPMC10558427
|
biostudies-literature
Cite
(
E
)-
N
-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies.
Not available
S-EPMC9697799
|
biostudies-literature
Cite
Computer-Assisted Drug Discovery of a Novel Theobromine Derivative as an EGFR Protein-Targeted Apoptosis Inducer.
Not available
S-EPMC10693208
|
biostudies-literature
Cite
Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2.
Not available
S-EPMC10663924
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets